Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

PICS Guide in 2026: GMP Inspection Checklist and Compliance

This article explains how GMP inspections are structured using the PICS guideline, focusing on checklist execution, data integrity controls, and system-level compliance gaps. It highlights real inspection expectations and how companies can improve audit readiness effectively.
  • Blog, Quality Management System
GMP inspection checklist PICS based visual showing inspection expectations, data integrity review, and quality system gaps aligned with pharmaceutical inspection cooperation scheme standards and compliance evaluation process.

EU Annex 11 in 2026 GMP Inspection Requirements for Data Integrity and Computerized Systems

This article explores computerized system compliance in pharmaceutical environments, focusing on validation lifecycle, audit trail integrity, and risk-based approaches. It highlights regulatory expectations for electronic records, system controls, and inspection readiness under EU GMP frameworks and GxP standards.
  • Blog, Computerized System Validation, GMP
Pharmaceutical data integrity ALCOA plus EU GMP with system access control and audit trail compliance requirements in regulated systems.

Annex 1 in 2026 GMP Inspection Requirements for Sterile Manufacturing

This article explains how EU GMP Annex 1 defines sterile manufacturing requirements, focusing on contamination control strategy, cleanroom classification, and aseptic processing. It highlights GMP inspection findings and shows how facilities can improve compliance and inspection readiness effectively.
  • Blog, Validation and Qualification
EU GMP Annex 1 sterile manufacturing environment displaying cleanroom classification ISO 14644 compliance, aseptic processing operations, environmental monitoring systems, and GMP inspection-focused contamination control strategy CCS implementation.

GAMP 5 in 2026: Trends and Compliance Insights

This article explains computerized system validation in regulated environments, focusing on CSV life cycle controls, data integrity compliance, and risk-based validation principles. It also highlights inspection expectations, supplier assessment guidance, and audit trail requirements under FDA Part 11 and EU
  • Blog, Validation and Qualification
Computerized system validation workflow showing validation lifecycle model, supplier assessment guidance, and audit trail requirements aligned with FDA Part 11 electronic records and EU Annex 11 requirements.

Pharmacovigilance Salary in 2026: Global Pay Trends

This article explores global pharmacovigilance salary trends, including PV specialist pay, drug safety salary ranges, and regional differences. It explains how entry level PV salary evolves into PV manager compensation across global pharmaceutical markets.
  • Blog, Quality Management System
Infographic showing pharmacovigilance salary trends worldwide, including pharmacovigilance specialist pay, drug safety salary differences, entry level PV salary, and regional PV wage trends across major global markets.

Pharmacovigilance history in 2026: Key Safety Milestones

This article explores pharmacovigilance history and its impact on modern inspection standards, while also addressing evolving drug safety systems, regulatory milestones, and how global pharmacovigilance salary trends reflect the growing complexity of compliance and risk management expectations.
  • Blog, GMP
Pharmacovigilance specialist reviewing drug safety data dashboards in a global compliance center reflecting pharmacovigilance salary trends, PV specialist salary insights, and regional pharmacovigilance jobs pay analysis

cGMP in 2026: Inspection Expectations and Compliance Gaps

This article explores key FDA inspection priorities in pharmaceutical manufacturing, focusing on data integrity controls, CAPA effectiveness, audit trail review, and common quality system failures. It also explains how companies can reduce regulatory risks and improve compliance readiness.
  • Blog, Quality Management System
Infographic showing FDA inspection priorities including data integrity controls, CAPA effectiveness, audit trail review, GMP compliance checklist elements, and common pharmaceutical quality system failures in regulatory inspections.

GMP Audit in 2026: Inspection Readiness and Control Gaps

This article explains how GMP audits evaluate inspection readiness through structured checklists, data integrity controls, CAPA effectiveness, and audit trail reviews. It highlights common findings, root causes, and how quality systems can improve compliance performance and inspection outcomes.
  • Blog, Quality Management System
GMP compliance checklist infographic showing inspection readiness elements, data integrity audit controls, CAPA effectiveness tracking, and audit trail review processes in pharmaceutical quality systems.